Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein.

RPEP-066242022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

The peptide achieves single-digit nanomolar inhibition of SARS-CoV-2.

Key Numbers

How They Did This

The study involved structural analysis of the spike protein and testing the peptide's effectiveness in cell-based and virus-based assays.

Why This Research Matters

This research is significant as it addresses the urgent need for effective antiviral treatments against evolving SARS-CoV-2 variants. The findings may lead to new therapeutic options that are less susceptible to mutations.

What This Study Doesn't Tell Us

The study primarily focuses on in vitro results, which may not fully translate to clinical effectiveness in humans.

Trust & Context

Original Title:
Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein.
Published In:
Proceedings of the National Academy of Sciences of the United States of America, 119(40), e2210990119 (2022)
Database ID:
RPEP-06624

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-06624·https://rethinkpeptides.com/research/RPEP-06624

APA

Yang, Kailu; Wang, Chuchu; Kreutzberger, Alex J B; Ojha, Ravi; Kuivanen, Suvi; Couoh-Cardel, Sergio; Muratcioglu, Serena; Eisen, Timothy J; White, K Ian; Held, Richard G; Subramanian, Subu; Marcus, Kendra; Pfuetzner, Richard A; Esquivies, Luis; Doyle, Catherine A; Kuriyan, John; Vapalahti, Olli; Balistreri, Giuseppe; Kirchhausen, Tom; Brunger, Axel T. (2022). Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein.. Proceedings of the National Academy of Sciences of the United States of America, 119(40), e2210990119. https://doi.org/10.1073/pnas.2210990119

MLA

Yang, Kailu, et al. "Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein.." Proceedings of the National Academy of Sciences of the United States of America, 2022. https://doi.org/10.1073/pnas.2210990119

RethinkPeptides

RethinkPeptides Research Database. "Nanomolar inhibition of SARS-CoV-2 infection by an unmodifie..." RPEP-06624. Retrieved from https://rethinkpeptides.com/research/yang-2022-nanomolar-inhibition-of-sarscov2

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.